首页 | 官方网站   微博 | 高级检索  
     

群体药代动力学及其在新药研究中的应用
引用本文:盛玉成,郑青山.群体药代动力学及其在新药研究中的应用[J].中国临床药理学与治疗学,2004,9(12):1333-1337.
作者姓名:盛玉成  郑青山
作者单位:安徽省药物临床评价中心,皖南医学院弋矶山医院,芜湖,241001,安徽
摘    要:近年来新药临床研究越来越重视群体药代动力学的应用。群体药代动力学可以定量地描述病理、生理、合并用药等多种因素对药物代谢的影响,可将PK参数中的各种变异区分开,指导用药方案的调整,从而增强对新药有效性和安全性的评价。本文对群体药代动力学的研究方法及其在新药研究中的应用进行综述.

关 键 词:药代动力学  群体药代动力学  非线性混合效应模型法  数学模型  固定效应
文章编号:1009-2501(2005)12-1333-05
修稿时间:2004年12月16

Population pharmacokinetics and its application in new drug development
SHENG Yu-Cheng,ZHENG Qing-Shan Anhui Provincial Center for Drug Clinical Evaluation,Yijishan Hospital,Wannan Medical College,Wuhu ,Anhui,China.Population pharmacokinetics and its application in new drug development[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2004,9(12):1333-1337.
Authors:SHENG Yu-Cheng  ZHENG Qing-Shan Anhui Provincial Center for Drug Clinical Evaluation  Yijishan Hospital  Wannan Medical College  Wuhu  Anhui  China
Affiliation:SHENG Yu-Cheng,ZHENG Qing-Shan Anhui Provincial Center for Drug Clinical Evaluation,Yijishan Hospital,Wannan Medical College,Wuhu 241001,Anhui,China
Abstract:There is an increasing focus on the application of populatio n pharmacokinetics(PPK) in new drug development. The population PK approach can quantitative explore relationships among the pharmacokinetics, pathophysiologic features and concomitant medications. The variability of PK parameters within th e population can be estimated and dosages can be appropriately modified, and thi s approach can increase the evaluation of safety and efficacy for the new drug. This article reviews the approach of population pharmacokinetics and its applica tion in new drug develepment.
Keywords:population pharmacokinetics  nonlinear mixed effect model  ma thematical model  fixed effects  pharmacokinetics
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号